Treatment Set TS349815 is a Intradermal; Subcutaneous Injection, Solution in the Non-standardized Allergenic category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Dermatophagoides Farinae; Penicillium Chrysogenum Var. Chrysogenum; Aspergillus Fumigatus.
| Product ID | 49288-0924_e266b12c-c311-4e1b-9d5a-1f448a15eb0e |
| NDC | 49288-0924 |
| Product Type | Non-standardized Allergenic |
| Proprietary Name | Treatment Set TS349815 |
| Generic Name | Treatment Set Ts349815 |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1986-10-31 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102223 |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | DERMATOPHAGOIDES FARINAE; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; ASPERGILLUS FUMIGATUS |
| Active Ingredient Strength | 2000 [AU]/mL; g/mL; g/mL |
| Pharm Classes | Allergens [CS],Insect Proteins [CS],Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [CS],Allergens [CS],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Fungal Proteins [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 1986-10-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA102223 |
| Product Type | NON-STANDARDIZED ALLERGENIC |
| Marketing Start Date | 1986-10-31 |
| Inactivation Date | 2019-11-27 |
| Ingredient | Strength |
|---|---|
| DERMATOPHAGOIDES FARINAE | 2000 [AU]/mL |